Fractional flow reserve: Key market research findings
- Regulatory approvals to drive market growth
- The Americas to dominate the market geographically
- Key vendors – ACIST, Boston Scientific, Opsens, St.Jude Medical, and Volcano
Technavio’s market research analysts predict the global fractional flow reserve market to grow at a CAGR of over 14% between 2016 and 2020. The market’s growth is fueled primarily by the increasing need to diagnose coronary artery diseases (CAD). Fractional flow reserve simplifies angiographic interpretation, resulting in improved diagnosis and superior treatment decisions. In 2015, the Americas accounted for around 52% of the total global fractional flow reserve market share, with the US being the largest revenue generator. Regulatory approvals of new fractional flow reserve products in the US will fuel the market, and collaborations between complementary players are expected to propel growth in the fractional flow reserve market in the Americas during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of the fractional flow reserve segments based on the application.
“Recently, there has been an increase in clinical trials and regulatory approvals in the fractional flow reserve market. The growing demand for fractional flow reserve technology is prompting new companies in the market to develop products that are cost-effective. As a result, companies are constantly seeking ways to gain approvals and launch new products,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
By 2020, the multi-vessel segment is expected to account for around 63% of the market to continue its dominion over the global the fractional flow reserve market. Fractional flow reserve measurement is critical for individuals suffering from multivessel disease, as it can wholly reshape the revascularization strategy. The more judicious use of stents during the treatment of myocardial ischemia in the procedure enhances the clinical outcome and decreases healthcare costs. For instance, myocardial perfusion scintigraphy is limited in accurately localizing lesions responsible for ischemia.
ACIST, Boston Scientific, Opsens, St.Jude Medical, and Volcano are the prominent players in the market. Owing to the recent rise in the number of vendors, this market has witnessed an increase in new regulatory approvals and vendors are constantly developing new technologies to occupy a considerable share of the market. They are also conducting additional studies to expand the application of FFR to diagnose other cardiac diseases.
A more detailed analysis is available in the Technavio report, Global Fractional Flow Reserve Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
